The Dutch giant now poised for much better times
29/04/24 -"While our earnings estimates have reset higher, the extent of the upgrade is limited compared with the fundamental metrics (DCF and NAV) given that our numbers are already on the high side when ..."
Pages
63
Language
English
Published on
29/04/24
You may also be interested by these reports :
16/05/24
On the back of the promising beginning to 2024, which was a combination of 1/ normalising market demand in Europe (the lynchpin geography); 2/ the ...
16/05/24
As we have consistently argued over the last 3 years, Health stocks (ex Pharma) are long on growth promises and short on delivery. The gap stems from ...
15/05/24
Bastide reported stronger organic growth in Q3 than in the previous two quarters. The group is currently spinning off two Swiss subsidiaries, which ...
15/05/24
Orpea published overall good-looking organic revenue in the Q1, primarily led by improvements in the international performance while its activities ...